25% of IDIBELL staff is smoker May 31 is the World without Snuff. The Smoke-Free IDIBELL program is aimed at workers ready to quit smoking. It is a free personalized program offered by the Tobacco Control Unit of the ICO. To qualify for the Smoke-Free program IDIBELL, the smoker must be motivated to quit. According […]
A study led by Manel Esteller compares the epigenetic marks of a healthy person with a patient with a genetic disease Methylation Article’s reference:
First epigenome in Europe completed Read More »
The diagnosis of male fertility is usually performed through the observation of the sperm in the microscope. However, a normal quality semen does not guarantee an adequate fertility. In fact, there is a considerable proportion of cases of unexplained infertility and data suggest that abnormal sperm function may have a genetic or molecular origin. A
Identify genetic markers to predict male fertility Read More »
Alterations in the formation of ribosomes (the elements of the cell where proteins are made) cause the induction of p53 protein and cell cycle disruption. This process is crucial to understand fundamental biological processes and the emergence of various diseases. Now, scientists at the Bellvitge Biomedical Research Institute (IDIBELL) have found that this response is
Discovered a new checkpoint of cell cycle control through joint action of two proteins Read More »
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have identified the mechanism by which protein Zds1 regulates a key function in mitosis, the process that occurs immediately before cell division. The result has been achieved in the online edition of the Journal of Cell Science and opens the door to developing targeted and direct therapies
New key mechanism in cell division discovered Read More »
The Bellvitge Biomedical Research Institute (IDIBELL) has recruited the researcher George Thomas, one of the leading international scientists in cancer and metabolic diseases. Dr. Thomas’ research focuses on the metabolic processes that are behind human diseases, which has led him to similar findings in apparently different diseases such as cancer, diabetes and obesity. George Thomas
Top researcher George Thomas joins IDIBELL Read More »
The Catalan Minister of Health, Boi Ruiz, has inaugurated the new Laboratory of Metabolism and Cancer of IDIBELL. The opening ceremony, held on May 11th, was attended by the mayor of L’Hospitalet de Llobregat, Nuria Marin, and representatives of IDIBELL partner institutions (Bellvitge University Hospital, Catalan Institute of Oncology and the University of Barcelona) as
The Minister of Health inaugurates new lab on Metabolism and Cancer Read More »
The journal Nature has published in its first issue of May, a commentary by the director of the IDIBELL’s Metabolism and Cancer research group, George Thomas, and the researcher of the same group Antonio Gentilella. Los investigadores hablan sobre dos estudios publicados en el mismo número de la revista, sobre la proteína quinasa mTOR, un
George Thomas and Antonio Gentilella publish a comment on Nature Read More »
The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute (IDIBELL). The study results are been published on the online edition of the journal Science Translational Medicine. Primary
Combination of two drugs reverses liver tumours Read More »
The Catalan Institute of Oncology (ICO) L’Hospitalet has been recognized with the ‘gold standard’ of the Global Network for Tobacco Free Health Care Services (ENSH). This is the highest international distinction given to those health centers that have demonstrated significant progress in tobacco control policies and represent an example for other organizations in the fight
ICO receives the highest international distinction for his fight against smoking Read More »
